Porphyrin Precursors in Sulfanilamidopyrimidin Treatment
- 1 January 1967
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 20 (2), 176-178
- https://doi.org/10.3109/00365516709076939
Abstract
Thirty apparently healthy individuals were treated with 5-methoxi-2-sulfanilamidopyrimidin for five days. The 24-hour urinary excretion of delta-aminolaevulic acid (ALA) and porphobilinogen (PBG) was determined before and after treatment. A significant increase in the urinary ALA excretion and decrease in the PBG excretion was found.Keywords
This publication has 5 references indexed in Scilit:
- Activity of Amino-laevulinic Acid Synthetase in Normal and Porphyric Human LiversNature, 1966
- THE OCCURRENCE AND DETERMINATION OF δ-AMINOLEVULINIC ACID AND PORPHOBILINOGEN IN URINEJournal of Biological Chemistry, 1956
- OCCURRENCE AND DETERMINATION OF DELTA-AMINOLEVULINIC ACID AND PORPHOBILINOGEN IN URINE1956
- STUDIES ON THE TOXICITY OF SULFONAMIDE DRUGS .1. PORPHYRIN-EXCRETION BY A PATIENT TREATED WITH SULFADIAZINE AND LATER WITH SULFANILAMIDE1946
- PORPHYRINURIA FOLLOWING SULPHANILAMIDE :: SULPHANILAMIDE DERMATITISThe Lancet, 1938